Sony of Tokyo has received US Patent No.
Luminex President and CEO Patrick Balthrop has been elected to the Personalized Medicine Coalition's board of directors for a three-year term.
The firm's new Oracle 3D glass nanowell microarray substrates are targeted towards customers that use protein arrays for research, in drug discovery, and, potentially, in the clinic.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.